Dr. Waleed Abuzeid is an Assistant Professor in the Department of Otorhinolaryngology: Head and Neck Surgery at the Albert Einstein College of Medicine.  He received his medical degree from University College London (UCL) in the United Kingdom.  He went on to complete a 2 year post-doctoral research fellowship at the University of Pennsylvania.  Dr. Abuzeid graduated from the University of Michigan Department of Otolaryngology: Head and Neck Surgery residency program.  He then completed a fellowship in endoscopic sinus surgery and skull base surgery at Stanford University. 

Dr. Abuzeid provides comprehensive care for sinus disease incorporating the range of medical and surgical treatments. Furthermore, Dr. Abuzeid also cares for patients with skull base tumors, sinus or nasal tumors, cerebrospinal fluid (CSF) leak, and sinonasal allergy.  His research is focused on the discovery and development of novel molecular therapies for head and neck cancer, including cancers of the skull base. Dr. Abuzeid has received competitive research grants for this work. Most recently, he is collaborating with other investigators at Einstein to study cutting-edge treatments for bacterial biofilms which are key mediators of chronic rhinosinusitis, and to develop new and safer techniques for the diagnosis of aspirin-exacerbated respiratory disease, a particularly severe form of chronic sinusitis.

Dr. Abuzeid has published many peer-reviewed journal articles on both translational research and clinical subjects in the field of otolaryngology: head and neck surgery, and has co-authored multiple textbook chapters.  He has presented at many national meetings including the American Academy of Otolaryngology: Head and Neck Surgery, the American Head and Neck Society, the American Association for Cancer Research, and the North American Skull Base Society.  He is a member of the American Academy of Otolaryngology: Head and Neck Surgery, the American Rhinologic Society, and the North American Skull Base Society. 

Full publication list can be found at: http://www.ncbi.nlm.nih.gov/sites/myncbi/1dgRxbxEzWTA7/bibliography/47481491/public/?sort=date&direction=ascending

Selected publications:

1. Lajud SA, Nagda DA, Yamashita T, Zheng J, Tanaka N, Abuzeid WM, Civantos A, Bezpalko O, O’Malley BW Jr, Li D.  Dual disruption of DNA repair and telomere maintenance for the treatment of head and neck cancer.  Clinical Cancer Research 2014 Oct (E-published ahead of print)
2. Abuzeid WM, Bradford CR, Divi V.  Transoral robotic biopsy of the tongue base: a novel paradigm in the evaluation of unknown primary tumors of the head and neck.  Head & Neck 2013 Apr; 35(4): E126-30
3. Abuzeid WM, Akbar NA, Zacharek MA.  Vitamin D and chronic rhinitis.  Current Opinion in Allergy and Clinical Immunology 2012 Feb; 12(1): 13-7
4. Abuzeid WM, Davis S, Tang AL, Saunders L, Brenner JC, Lin J, Fuchs JR, Light E, Bradford CR, Prince ME, Carey TE.  Sensitization of head and neck cancer to cisplatin through the use of a novel curcumin analog.  Archives of Otolaryngology Head and Neck Surgery 2011 May; 137(5): 499-507
5. Abuzeid WM, Jiang X, Shi G, Wang H, Paulson DP, Araki K, Jungreis D, Carney J, O'Malley BW Jr, Li D.  Molecular disruption of Rad50 sensitizes human tumor cells to cisplatin-based chemotherapy.  Journal of Clinical Investigation 2009 Jul; 119(7): 1974-85
6. Li D, Guang W, Abuzeid WM, Roy S, Gao GP, Sauk JJ, O’Malley, Jr. BW.  A novel adenoviral gene delivery system targeted against the Hsp47 cell surface biomarker for human head and neck cancer.  Laryngoscope 2008 Apr; 118(4): 650-8